CLEARPOINT NEURO INC. - COMMON STOCK
11.84
22-十一月-24 16:44:58
15 分钟延时
股票
+0.75
+6.72%
今日范围
10.99 - 11.86
ISIN
N/A
来源
NASDAQ
-
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
22 1月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
16 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
08 1月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Third Quarter 2023 Results
09 11月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
26 10月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Second Quarter 2023 Results
08 8月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023
25 7月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
24 5月 2023 09:25:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
18 5月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports First Quarter 2023 Results
11 5月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
10 5月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
28 4月 2023 16:42:12 条件 Nasdaq GlobeNewswire
-
20 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
18 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
13 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
11 4月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
28 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results
01 3月 2023 16:05:01 条件 Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023
15 2月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
11 1月 2023 08:00:00 条件 Nasdaq GlobeNewswire